1,2-Bis[(2S,5S)-2,5-diethylphospholano]benzene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate

• Catalog No.: 698385
• CAS Number: 213343-64-7
• M. F.: C30H48BF4P2Rh
• M. W.: 660.3597548

SYNONYMS

• Title: 1,2-双[(2S,5S)-2,5-二乙基膦烷基]苯(1,5-环辛二烯)四氟硼酸铑(I)
• IUPAC name: λ^1-rhodium(1+) ion (2S,5S)-1-{2-[(2S,5S)-2,5-diethylphospholan-1-yl]phenyl}-2,5-diethylphospholane cycloocta-1,5-diene tetrafluoroboranuide
• IUPAC Traditional name: λ^1-rhodium(1+) ion (2S,5S)-1-{2-[(2S,5S)-2,5-diethylphospholan-1-yl]phenyl}-2,5-diethylphospholane 1,5-cyclooctadiene tetrafluoroborate
• Synonyms: (S,S)-Et-DUPHOS-Rh

DATABASE IDS

• CAS Number: 213343-64-7

PROPERTIES

• Empirical Formula (Hill Notation): C30H48BF4P2Rh
• Personal Protective Equipment: Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
• German water hazard class: 3

DETAILS

Description (English)

Packaging
50, 250 mg in glass bottle
Legal Information
Sold in collaboration with Kanata Chemical Technologies Inc. for research purposes only. These compounds were made and sold under license from E.I. du Pont de Nemours and Company, which license does not include the right to use the compounds in producing products for sale in the pharmaceutical field.
Application
DuPhos and BPE Ligands: Highly Efficient Privileged LigandsCatalyst for:
• Preparation of a key unit B precursor of cryptophycins via Horner-Wadsworth-Emmons reaction and asymmetric hydrogenation1
• Preparation of constrained phenylalanine analogs via Heck reaction followed by asymmetric hydrogenation and cyclization steps2
• Enantioselective preparation of N-benzyloxy-β-amino acid Me esters by hydrogenation of α-(benzyloxyaminomethyl)acrylate stereoisomers3
• Preparation of fluoro amino acids as synthons for potent macrocyclic HCV NS3 protease inhibitors4
• Stereoselective preparation of triply isotope-labeled Ser, Cys, and Ala5
• Preparation of β-amino acids from asymmetric hydrogenation of α-(aminomethyl)acrylates6
• Asymmetric hydrogenation of a-primary and secondary amino ketones and asymmetric synthesis of (-)-arbutamine and (-)-denopamine7

Description (简体中文)

包装
50, 250 mg in glass bottle
Legal Information
与 Kanata Chemical Technologies Inc. 联合销售，仅供研究使用。这些化合物由 E.I. du Pont de Nemours and Company 授权制造和销售，此许可不包括利用这些化合物制备在制药领域销售的产品的权利。
Application
DuPhos and BPE Ligands: Highly Efficient Privileged LigandsCatalyst for:
• Preparation of a key unit B precursor of cryptophycins via Horner-Wadsworth-Emmons reaction and asymmetric hydrogenation1
• Preparation of constrained phenylalanine analogs via Heck reaction followed by asymmetric hydrogenation and cyclization steps2
• Enantioselective preparation of N-benzyloxy-β-amino acid Me esters by hydrogenation of α-(benzyloxyaminomethyl)acrylate stereoisomers3
• Preparation of fluoro amino acids as synthons for potent macrocyclic HCV NS3 protease inhibitors4
• Stereoselective preparation of triply isotope-labeled Ser, Cys, and Ala5
• Preparation of β-amino acids from asymmetric hydrogenation of α-(aminomethyl)acrylates6
• Asymmetric hydrogenation of a-primary and secondary amino ketones and asymmetric synthesis of (-)-arbutamine and (-)-denopamine7